SARS: clinical presentation, transmission, pathogenesis and treatment options

被引:30
作者
Chan, PKS
Tang, JW
Hui, DSC
机构
[1] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Shatin, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Ctr Emerging Infect Dis, Fac Med, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
coronavirus; inflammation; respiratory infection; severe acute respiratory syndrome (SARS); viral transmission;
D O I
10.1042/CS20050188
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
SARS (severe acute respiratory syndrome) appeared as the first emerging infectious disease of this century. It is fortunate that the culprit virus can be grown without much difficulty from a commonly used cell line, allowing an unlimited supply of isolates for further molecular studies and leading to the development of sensitive diagnostic assays. How the virus has successfully jumped the species barrier is still a mystery. The superspreading events that occurred within hospital, hotel and high-density housing estate opens a new chapter in the mechanisms and routes of virus transmission. The old practice of quarantine proved to be still useful in controlling the global outbreak. Despite all the available sophisticated tests, alertness with early recognition by healthcare workers and prompt isolation of suspected cases is still the most important step for containing the spread of the infection. Although the rapidly evolving outbreak did not allow the conducting of systematic clinical trails to evaluate treatment options, the accumulated experience on managing SARS patients will improve the clinical outcome should SARS return. Although SARS led to more than 700 deaths worldwide, the lessons learnt have prepared healthcare systems worldwide to face future emerging and re-emerging infections.
引用
收藏
页码:193 / 204
页数:12
相关论文
共 150 条
[11]   Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units [J].
Booth, TF ;
Kournikakis, B ;
Bastien, N ;
Ho, J ;
Kobasa, D ;
Stadnyk, L ;
Li, Y ;
Spence, M ;
Paton, S ;
Henry, B ;
Mederski, B ;
White, D ;
Low, DE ;
McGeer, A ;
Simor, A ;
Vearncombe, M ;
Downey, J ;
Jamieson, FB ;
Tang, P ;
Plummer, F .
JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (09) :1472-1477
[12]   Severe acute respiratory syndrome coroavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides [J].
Bosch, BJ ;
Martina, BEE ;
van der Zee, R ;
Lepault, J ;
Haijema, BJ ;
Versluis, C ;
Heck, AJR ;
de Groot, R ;
Osterhaus, ADME ;
Rottier, PJM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (22) :8455-8460
[13]   Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS [J].
Bukreyev, A ;
Lamirande, EW ;
Buchholz, UJ ;
Vogel, LN ;
Elkins, WR ;
St Claire, M ;
Murphy, BR ;
Subbarao, K ;
Collins, PL .
LANCET, 2004, 363 (9427) :2122-2127
[14]   Clinical significance of hepatic derangement in severe acute respiratory syndrome [J].
Chan, Henry Lik-Yuen ;
Kwan, Ambrose Chi-Pong ;
To, Ka-Fai ;
Lai, Sik-To ;
Chan, Paul Kay-Sheung ;
Leung, Wai-Keung ;
Lee, Nelson ;
Wu, Alan ;
Sung, Joseph Jao-Yiu .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (14) :2148-2153
[15]   Retrospective analysis of liver function derangement in severe acute respiratory syndrome [J].
Chan, HLY ;
Leung, WK ;
To, KF ;
Chan, PKS ;
Lee, N ;
Wu, A ;
Tam, JSL ;
Sung, JJY .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (08) :566-567
[16]   Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS) [J].
Chan, JWM ;
Ng, CK ;
Chan, YH ;
Mok, TYW ;
Lee, S ;
Chu, SYY ;
Law, WL ;
Lee, MP ;
Li, PCK .
THORAX, 2003, 58 (08) :686-689
[17]  
Chan K. S., 2003, Hong Kong Medical Journal, V9, P399
[18]   Persistent infection of SARS coronavirus in colonic cells in vitro [J].
Chan, PKS ;
To, KF ;
Lo, AWI ;
Cheung, JLK ;
Chu, I ;
Au, FWL ;
Tong, JHM ;
Tam, JS ;
Sung, JJY ;
Ng, HK .
JOURNAL OF MEDICAL VIROLOGY, 2004, 74 (01) :1-7
[19]   Severe acute respiratory syndrome-associated coronavirus infection [J].
Chan, PKS ;
Ip, M ;
Ng, KC ;
Chan, RCW ;
Wu, A ;
Lee, N ;
Rainer, TH ;
Joynt, GM ;
Sung, JJY ;
Tam, JS .
EMERGING INFECTIOUS DISEASES, 2003, 9 (11) :1453-1454
[20]   In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds [J].
Chen, F ;
Chan, KH ;
Jiang, Y ;
Kao, RYT ;
Lu, HT ;
Fan, KW ;
Cheng, VCC ;
Tsui, WHW ;
Hung, IFN ;
Lee, TSW ;
Guan, Y ;
Peiris, JSM ;
Yuen, KY .
JOURNAL OF CLINICAL VIROLOGY, 2004, 31 (01) :69-75